medigraphic.com
ISSN 2007-3178 (Print)
Asociación Mexicana de Cirugía Bucal y Maxilofacial, Colegio Mexicano de Cirugía Bucal y Maxilofacial, A.C.

2026, Number 1

<< Back Next >>

Rev Mex Cir Bucal Maxilofac 2026; 22 (1)

Knowledge, attitudes and practices of dentistry students regarding the management of patients under antithrombotic therapy

Prado BNY, Cruz FA, Chaves CIA, Salgado CF

Language: Spanish
References: 26
Page: 4-11
PDF size: 446.19 Kb.


ABSTRACT

Introduction: the dental management of patients receiving antithrombotic therapy remains a clinical challenge due to the potential bleeding risk and the frequent misconception that medication must be discontinued before dental extraction. Current evidence indicates that most procedures can be safely performed without interrupting therapy when appropriate local hemostatic measures are implemented. Objective: to evaluate the knowledge, attitudes, and practices of dentists regarding the management of patients under antithrombotic therapy, particularly concerning drug discontinuation prior to tooth extraction. Material and methods: a cross-sectional observational study was conducted through a structured questionnaire distributed among dentists from various healthcare institutions. The survey assessed the identification of anticoagulant and antiplatelet agents, evaluation of bleeding risk, decisions regarding therapy suspension, and management of postoperative complications. Descriptive statistics were used for frequency and percentage analysis. Results: although most respondents identified the main antithrombotic drugs, uncertainty persisted regarding therapy discontinuation. Sixty-two percent considered it necessary to suspend the medication before extraction, and only 28% were aware of clinical guidelines discouraging this practice. Forty percent reported feeling insecure when treating these patients, and over 70% had not received specific training on the subject. Conclusions: sufficient knowledge was identified among dentists but inconsistent regarding the management of patients under antithrombotic therapy. Lack of awareness of current recommendations may increase thromboembolic and some trans or postoperative hemorrhagic risks, underscoring the need to strengthen professional education in pharmacology and clinical management.


REFERENCES

  1. Schafer A, Flierl U, Berliner D, Bauersachs J. Anticoagulants forstroke prevention in atrial fibrillation in elderly patients. CardiovascDrugs Ther. 2020; 34 (4): 555-568. doi: 10.1007/s10557-020-06981-3.

  2. Chen A, Stecker E, Warden BA. Direct oral anticoagulant use: apractical guide to common clinical challenges. J Am Heart Assoc.2020; 9 (13): e017559. doi: 10.1161/JAHA.120.017559.

  3. Teoh L, Moisés G, McCullough MJ. A review of drugs contributingto bleeding risk in general dental practice. Aust Dent J. 2020; 65(2): 118-130.

  4. Nazar JC, Cárdenas CA, Coloma DR, Contreras CJ, MolinaI, Miranda HP et al. Manejo perioperatorio de pacientes contratamiento anticoagulante crónico. Rev Chil Cir. 2018; 70 (1): 84-91.

  5. Cebollada-del Misterio JM, Pérez-Contreras ME, RodríguezÁlvarezM, Noguera-Franco M, Vilavella-Lizana C. Manejo deantiagregantes y anticoagulantes en el perioperatorio. FMC FormMed Contin Aten Prim. 2019; 26 (2): 104-115. doi: 10.1016/j.fmc.2018.09.002.

  6. Johnson-Leong C. An evidence summary of the management ofpatients taking direct oral anticoagulants (DOACs) undergoingdental surgery. Int J Oral Maxillofac Surg. 2016; 45 (5): 618-630.

  7. O’Connell JE, Stassen LFA. New oral anticoagulants and theirimplications for dental patients. J Ir Dent Assoc. 2014; 60 (3):137-143.

  8. Van Diermen DE, Van der Waal I, Hoogvliets MW, Ong FN,Hoogstraten J. Survey response of oral and maxillofacial surgeonson invasive procedures in patients using antithrombotic medication.Int J Oral Maxillofac Surg. 2013; 42 (4): 502-507. doi: 10.1016/j.ijom.2012.09.018.

  9. Bensi C, Belli S, Paradiso D, Lomurno G. Postoperative bleedingrisk of direct oral anticoagulants after oral surgery procedures: asystematic review and meta-analysis. Int J Oral Maxillofac Surg.2018; 47 (7): 923-932.

  10. Broekema FI, Van Minnen B, Jansma J, Bos RRM. Risk of bleedingafter dentoalveolar surgery in patients taking anticoagulants. Br JOral Maxillofac Surg. 2014; 52 (3): e15-e19.

  11. Melgaard L, Gorst-Rasmussen A, Lane DA, Rasmussen LH,Larsen TB, Lip GYH. Assessment of the CHA2DS2-VASc scorein predicting ischemic stroke, thromboembolism, and death inpatients with heart failure with and without atrial fibrillation. JAMA.2015; 314 (10): 1030-1038. doi: 10.1001/jama.2015.10725.

  12. Serrano-Sánchez V, Ripollés-de Ramón J, Collado-Yurrita L,Vaello-Checa I, Colmenero-Ruiz C, Helm A et al. New horizons inanticoagulation: direct oral anticoagulants and their implicationsin oral surgery. Med Oral Patol Oral Cir Bucal. 2017; 22 (5):e601-e608. doi: 10.4317/medoral.21862.

  13. Martínez-Moreno E, Martínez-López F, Rodríguez-Lozano FJ,Oñate-Sánchez RE. Bleeding complications in anticoagulated and/or antiplatelet-treated patients at the dental office: a retrospectivestudy. Int J Environ Res Public Health. 2021; 18 (4): 1609. doi:10.3390/ijerph18041609.

  14. Zhu W, He W, Guo L, Wang X, Hong K. The HAS-BLED score forpredicting major bleeding risk in anticoagulated patients with atrialfibrillation: a systematic review and meta-analysis. Clin Cardiol.2015; 38 (9): 555-561. doi: 10.1002/clc.22435.

  15. Obamiro KO, Chalmers L, Bereznicki LR. Development andvalidation of an oral anticoagulation knowledge tool (AKT). PLoSOne. 2016; 11 (6): e0158071. doi: 10.1371/journal.pone.0158071.

  16. Ramírez-Prieto G, Pombo-Bartelt JE, Rojas-Calderón G, García-González JJ. Prescripción de anticoagulación oral en el pacientegeriátrico con fibrilación auricular. Arch Cardiol Mex. 2022; 92 (1):42-52.

  17. Torres-Martínez JM. Estilos de vida de los pacientes anticoaguladosvista desde el modelo de creencias de salud. Rev Mex EnfermCardiol. 2022; 30 (2): 47-54.

  18. Srivastava KC, Shrivastava D, Baig MN, Sghaireen MG, KielbassaAM, Lynch E. Knowledge, attitude, and practice of institutionaldental professionals regarding management of patients taking oralantithrombotic medications. Acad J. 2020; 51 (8): 650.

  19. Sánchez-Fúnez S. Conocimientos de los alumnos de odontologíasobre fármacos antiagregantes y anticoagulantes [tesis delicenciatura]. Barcelona: Universitat de Barcelona, Facultat deMedicina i Ciéncies de la Salut; 2023.

  20. van Diermen DE, Bruers JJ, Hoogstraten J, Bovenlander M, vanden Bosch A, van der Waal I. Treating dental patients who use oralantithrombotic medication: a survey of dentists in the Netherlands.J Am Dent Assoc. 2011; 142 (12): 1376-1382.

  21. Bayón J, Gordo V, Santás-Álvarez M, Lozano I, Ríos-VázquezR, González-Juanatey C. Grado de conocimiento de losanticoagulantes orales y la fibrilación auricular entre los odontólogosde España. REC: CardioClinics. 2019; 54 (2): 133-135.

  22. Shah AH, Khalil HS, Alshahrani FA, Khan SQ, AlQthani NR,Bukhari IA et al. Knowledge of medical and dental practitionerstowards dental management of patients on anticoagulant and/orantiplatelet therapy. Saudi J Dent Res. 2015; 6 (2): 91-97. doi:10.1016/j.sjdr.2014.10.002.

  23. Palareti G, Antonucci E, Mastroiacovo D, Ageno W, Pengo V, PoliD et al. The American College of Chest Physicians score to assessthe risk of bleeding during anticoagulation in patients with venousthromboembolism. J Thromb Haemost. 2018; 16 (10): 1994-2002.

  24. Moldovan MA, Filip LV, Ciurea M, Termure DA, Ostas D, RotarH et al. Bleeding and thromboembolic risk in patients underanticoagulant therapy receiving oral surgery: a systematic review.Med Pharm Rep. 2023; 96 (4): 346-357. doi: 10.15386/mpr-2519.

  25. Barnes GD, Mouland E. Peri-procedural management of oralanticoagulants in the DOAC era. Prog Cardiovasc Dis. 2018; 60(6): 600-606. doi: 10.1016/j.pcad.2018.03.002.

  26. Sahar-Helft S, Chackartchi T, Polak D, Findler M. Dental treatmentin the era of new anti-thrombotic agents. Int Dent J. 2018; 68 (3):131-137.




2020     |     www.medigraphic.com